WO2014127927A1 - Produit de protection solaire contenant de l'éthylméthicone - Google Patents

Produit de protection solaire contenant de l'éthylméthicone Download PDF

Info

Publication number
WO2014127927A1
WO2014127927A1 PCT/EP2014/050507 EP2014050507W WO2014127927A1 WO 2014127927 A1 WO2014127927 A1 WO 2014127927A1 EP 2014050507 W EP2014050507 W EP 2014050507W WO 2014127927 A1 WO2014127927 A1 WO 2014127927A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
preparation according
cosmetic preparation
cosmetic
ethylhexyl
Prior art date
Application number
PCT/EP2014/050507
Other languages
German (de)
English (en)
Inventor
Miriam Belser
Svenja Lena Möllgaard
Sebastian Otto
Nicole JOHNS
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Priority to EP14700610.0A priority Critical patent/EP2958633A1/fr
Publication of WO2014127927A1 publication Critical patent/WO2014127927A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85Polyesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to a cosmetic preparation containing Octyldodecyl- citrate polyester (INCI: Octyldodecyl citrate crosspolymer with the CAS number 1 182066-69-8) and ethyl methicone.
  • ICI Octyldodecyl- citrate polyester
  • ethyl methicone ethyl methicone
  • UV radiation causes a pigmentation in the sense of melanin formation.
  • the ultraviolet radiation of sunlight also has a damaging effect on the skin.
  • long-term damage such as an increased risk of developing skin cancer occurs due to excessive exposure to light from the UVB range (wavelength: 280-320 nm).
  • the excessive action of the UVB and UVA radiation also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature skin aging.
  • UVA and UVB filters are in the form of positive lists in most industrialized countries such as Appendix 7 of the
  • Sunscreens are often used in conjunction with water sports activities (swimming, swimming, surfing, diving, etc.).
  • the so-called "whitening effect” occurs, in which parts of the preparation precipitate when applied or rubbed on the skin and no longer on the skin, forming an even protective film is no longer possible
  • This kind of destroyed cosmetic system also leads to a reduced UV protection, since the UV filters can no longer distribute themselves evenly on the skin and can move into it. This phenomenon occurs especially in sunscreen oils and alcoholic solutions, because of the Applying to the wet skin first requires a homogeneous combination with the water on the skin, then this homogeneous mixture must spread evenly over the skin.
  • a cosmetic preparation containing a) octyldodecyl citrate polyester (INCI: Octyldodecyl citrate crosspolymer having the CAS number 1 182066-69-8) and
  • Octyldodecyl citrate polyester (INCI: Octyldodecyl citrate crosspolymer with CAS number 1 182066-69-8) is available, for example, under the trade name Cosmosurf CE-100 from Surfa Tech Corporation.
  • preparation always means the preparation according to the invention, unless otherwise stated.
  • the preparation according to the invention contains one or more UV filters.
  • the preparation according to the invention is preferably a cosmetic sunscreen.
  • the preparation contains one or more UV filters selected from the group of compounds 2-phenylbenzimidazole-5-sulfonic acid and / or salts thereof; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidene-methyl) benzenesulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylene-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1
  • ethylhexyl salicylate Terephthalidendicamphersulfonklare; 4- (tert-butyl) -4'-methoxydibenzoylmethane;2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; Di (2-ethylhexyl) 4-methoxybenzalmalonate; 4-methoxycinnamate (2-ethylhexyl) ester; 4-methoxycinnamic acid isoyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone;2,2'-dihydroxy-4-methoxybenzophenone; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; homomenthy
  • Embodiments of the present invention which are particularly preferred according to the invention are characterized in that the preparation is free of 3- (4-methylbenzylidene) -camphor and 2-hydroxy-4-methoxybenzophenone (oxybenzone).
  • the preparation contains UV filters in the total amount of from 10 to 40% by weight, based on the total weight of the preparation. According to the invention, it is preferable if the preparation contains UV filters in the total amount of 12 to 30% by weight, based on the total weight of the preparation.
  • Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation octyldodecyl citrate polyester (INCI: octyldodecyl citrate crosspolymer having the CAS number 1 182066-69-8) in the total amount of 4 to 12% by weight, based on the total weight of the preparation, contains.
  • ICI octyldodecyl citrate crosspolymer having the CAS number 1 182066-69-8
  • Embodiments of the present invention which are preferred according to the invention are characterized in that the preparation octyldodecyl citrate polyester (INCI: octyldodecyl citrate crosspolymer having the CAS number 1 182066-69-8) in the total amount of 8 to 12% by weight, based on the total weight of the preparation, contains.
  • ICI octyldodecyl citrate crosspolymer having the CAS number 1 182066-69-8
  • Concentration of 1 to 5% by weight, based on the total weight of the preparation contains.
  • Concentration of 2 to 4% by weight, based on the total weight of the preparation contains.
  • the preparation contains ethylhexylglycerol and / or caprylylglycol, the combination of ethylhexylglycerol and caprylylglycol being very particularly preferred.
  • 1 -2 wt .-% water can be incorporated relatively easily without the preparation is cloudy. This does not mean that many formulas work with anhydrous ethanol, but can be resorted to the azeotrope.
  • Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation contains ethylhexylglycene in a concentration of 0.5 to 3% by weight, based on the total weight of the preparation.
  • Embodiments of the present invention which are preferred according to the invention are characterized in that the preparation contains ethylhexylglycene in a concentration of 0.5 to 2% by weight, based on the total weight of the preparation.
  • the preparation contains caprylyl glycol in a concentration of 0.5 to 3% by weight, based on the total weight of the preparation.
  • the preparation contains caprylyl glycol in a concentration of 0.5 to 2% by weight, based on the total weight of the preparation.
  • the preparation is an alcoholic solution.
  • the preparation is an ethanolic solution.
  • the preparation contains one or more gel formers. It can according to the composition of the
  • Hydroxymethylcellulose or hydroxypropylcellulose Hydroxymethylcellulose or hydroxypropylcellulose.
  • the preparations according to the invention advantageously contain one or more film formers.
  • Film formers in the context of the present invention are substances
  • a film former dissolved in water or other suitable solvents and then applies the solution to the skin, it forms after the evaporation of the solvent, a film which has a protective function substantially. It is particularly advantageous to use the film formers from the group of polymers based on polyvinylpyrrolidone (PVP).
  • PVP polyvinylpyrrolidone
  • copolymers of polyvinylpyrrolidone for example the PVP hexadecene copolymer and the PVP eicosene copolymer, which are available under the trade names Antaron V216 and Antaron V220 in the GAF Chemicals Cooperation.
  • polystyrene sulfonate sold under the tradename Flexan 130 at National Starch and Chemical Corp. and / or polyisobutene, available from Rewo under the tradename Rewopal PIB1000.
  • suitable polymers are e.g. Polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols.
  • hydrogenated castor oil Dimerdilinoleat (CAS 646054-62-8, INCI Hydrogenated Castor Oil Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H or PPG-3 Benzylethermyristat ( CAS 403517-45-3), which can be obtained under the trade name Crodamol STS from Croda Chemicals.
  • acrylates / octylacrylamide copolymer (BDF film 79, trade name Dermacryl 79 from Akzo Nobel).
  • Preparation is less than 4.5 wt .-% is.
  • the oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C atoms.
  • the fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semi-synthetic and natural oils, such as.
  • Cocoglyceride olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, thistle oil, evening primrose oil, macadamia nut oil and the like.
  • natural waxes of animal and vegetable origin such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).
  • further advantageous polar oil components can furthermore be selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of from 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or or unbranched alcohols having a chain length of 3 to 30 carbon atoms and from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
  • ester oils can then advantageously be selected from the group consisting of phenethyl benzoate, 2-phenylethyl benzoate, isopropyl lauroyl sarcosinate, phenyl trimethicone, cyclomethicone, dibutyl adipate,
  • the oil phase can be advantageously chosen from the group of dialkyl carbonates and dialkyl ethers (in particular dicaprylyl ether).
  • dialkyl carbonates and dialkyl ethers in particular dicaprylyl ether.
  • dicaprylyicarbonate available under the trade name Cetiol CC from Cognis.
  • oil phase of the formulations according to the invention has a content of C 12-15 -alkyl benzoate or consists entirely of this.
  • Olkomponenten are also z.
  • Butyloctyl salicylate for example that available under the trade name Hallbrite BHB from the company CP Hall
  • tridecyl salicylate for example that available under the trade name Hallbrite BHB from the company CP Hall
  • the preparation according to the invention comprises one or more active compounds selected from the group consisting of glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, caffeine, natural and / or synthetic isoflavonoids, glyceryl glucose, creatine, creatinine, taurine, tocopherol, tocopherol acetate, ⁇ -alanine and / or licochalcone A.
  • active compounds selected from the group consisting of glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, caffeine, natural and / or synthetic isoflavonoids, glyceryl glucose
  • the preparation according to the invention may advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those of low C number, such as isopropanol, diols or polyols of low C number, and their ethers, preferably
  • Propylene glycol 2-methylpropane-1,3-diol, pentane-1,2-diol, hexane-1,2-diol, octane-1,2-diol, decane-1,2-diol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products.
  • the preparation according to the invention advantageously contains one or more perfume substances.
  • the preparation according to the invention preferably contains one or more perfume substances selected from the group consisting of 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1, 1, 3,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C butylphenylmethylpropionalcinnamal, amylsalicylate, amylcinnamyl alcohol, anisalcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenylmethylpropioal, cardamom oil , Cedrol, Cinnamal,
  • the preparation is in the form of a pump spray.
  • all common pump spray applicators known for cosmetics in particular for sprayable sunscreens can be used.
  • the second of these advantageous embodiments is characterized in that the preparation is in the form of an aerosol spray.
  • the preparation contains as propellant propane, n-butane and / or isobutane. According to the invention are preferred
  • the preparation according to the invention is preferably presented in such a propellant gas can containing the cosmetic preparation.
  • the can is an aluminum can, which is coated on the inside with a protective lacquer.
  • Epoxyphenollack a polyamide-imide varnish or a powder coating is.
  • valve of the propellant gas can in the spray head contains a ball valve which allows a 360 ° application.
  • Ariane ball valves from Aptar.
  • the conical bore may advantageously be 1x 0.32 mm or 1x 0.44 mm or 1x 0.5 mm.
  • propellant cans according to the invention advantageously characterized in that is used as a spray head eg Cindy Lindal.
  • the third of these advantageous embodiments is characterized in that the preparation is in the form of a so-called bag-on-valve spray.
  • bag-on-valve applicators can be used.
  • the batch consists of 65% bulk and 35% propellant gas (60% butane + 20% isobutane + 20% propane, pressure rating 2.7 bar)
  • the ratio Bulk: Propellant may also be 60:40 or 70:30 or 75:25 or 80:20 or 85:15 or 90:10 or 95: 5.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Préparation cosmétique contenant a) du polyester de citrate d'octyldodécyle (INCI: Octyldodecyl citrate crosspolymer ayant le no CAS 1182066-69-8) et b) de l'éthylméthicone.
PCT/EP2014/050507 2013-02-25 2014-01-13 Produit de protection solaire contenant de l'éthylméthicone WO2014127927A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14700610.0A EP2958633A1 (fr) 2013-02-25 2014-01-13 Produit de protection solaire contenant de l'éthylméthicone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013203017.7 2013-02-25
DE102013203017.7A DE102013203017A1 (de) 2013-02-25 2013-02-25 Sonnenschutzmittel mit Ethylmethicon

Publications (1)

Publication Number Publication Date
WO2014127927A1 true WO2014127927A1 (fr) 2014-08-28

Family

ID=49989709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/050507 WO2014127927A1 (fr) 2013-02-25 2014-01-13 Produit de protection solaire contenant de l'éthylméthicone

Country Status (3)

Country Link
EP (1) EP2958633A1 (fr)
DE (1) DE102013203017A1 (fr)
WO (1) WO2014127927A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107019651A (zh) * 2015-10-09 2017-08-08 拜尔斯道夫股份有限公司 具有显著降低的由双‑乙基己氧苯酚甲氧苯基三嗪引起的织物污染的防晒剂

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015208869A1 (de) * 2015-05-13 2016-11-17 Beiersdorf Ag Alkoholhaltiges, octocrylenfreies Sonnenschutzmittel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007005334A1 (de) 2007-02-01 2008-08-07 Beiersdorf Ag Piperazinderivate in diolhaltigen kosmetischen Zubereitungen
US20120014882A1 (en) 2010-07-14 2012-01-19 Singleton Laura C Skin care compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236287B2 (en) * 2010-09-03 2012-08-07 Neutrogena Corporation Sunscreen compositions
US20130078204A1 (en) * 2011-09-28 2013-03-28 Susan Daly Topical sunscreen compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007005334A1 (de) 2007-02-01 2008-08-07 Beiersdorf Ag Piperazinderivate in diolhaltigen kosmetischen Zubereitungen
US20120014882A1 (en) 2010-07-14 2012-01-19 Singleton Laura C Skin care compositions
WO2012009405A2 (fr) 2010-07-14 2012-01-19 Neutrogena Corporation Compositions de soins de la peau

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"CosmoSurfTM CE Series High Definiton Polymers - Technical Data Sheet", 1 April 2010 (2010-04-01), pages 1 - 8, XP055113562, Retrieved from the Internet <URL:http://www.cossma.com/fileadmin/all/cossma/Archiv/ProductInfo/COS1103_44_BrenntagSiltecCosmosurf_CE_Brochure_2010.pdf> [retrieved on 20140410] *
"Suncare Compositions (2)", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 10 July 2012 (2012-07-10), XP013152445, ISSN: 1533-0001 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107019651A (zh) * 2015-10-09 2017-08-08 拜尔斯道夫股份有限公司 具有显著降低的由双‑乙基己氧苯酚甲氧苯基三嗪引起的织物污染的防晒剂

Also Published As

Publication number Publication date
DE102013203017A1 (de) 2014-08-28
EP2958633A1 (fr) 2015-12-30

Similar Documents

Publication Publication Date Title
EP2099425A1 (fr) Formulation cosmétique comprenant des glucosyle glycérides et des parfums choisis
EP2485805B1 (fr) Préparation cosmétique contenant des cétéarylsulfosuccinates et de la trisbiphényl-triazine
EP2874912B1 (fr) Nouveau spray cosmétique solaire
DE102007024345A1 (de) Kosmetische Zubereitung mit ionischem UV-A-Filter, 4-(tert.-Butyl)-4&#39;-methoxy-di-ben-zoylmethan und 2-Ethylhexyl-2cyano-3,3-di-phenyl-acrylat
EP2114907A2 (fr) Dérivés de pipérazine dans des préparations cosmétiques contenant des diols
WO2016026614A1 (fr) Préparation cosmétique stable
DE102007024342A1 (de) Kosmetische Zubereitung mit spezieller UV-Filterkombination
WO2014012705A2 (fr) Nouveau spray cosmétique solaire
WO2015150115A1 (fr) Préparation cosmétique de protection contre les uv à base d&#39;acrylate
EP1857096B1 (fr) Protection solaire pouvant être vaporisée
EP2485806B1 (fr) Utilisation de cétéarylsulfosuccinates dans des préparations cosmétiques de protection solaire
DE202013001754U1 (de) Sonnenschutzmittel zur Anwendung auf nasser Haut
DE102006006864A1 (de) Kosmetische Zubereitung mit Vinylpyrrolidon/Acrylsäure-Copolymer
WO2014191181A1 (fr) Préparation cosmétique, contenant de la polysilicone-25 et des filtres uv solubles dans l&#39;eau présentant une fonction d&#39;acide sulfonique
WO2014127927A1 (fr) Produit de protection solaire contenant de l&#39;éthylméthicone
EP2958542A1 (fr) Produit de protection solaire contenant du dialkyléther, destiné à être utilisé sur une peau humide
EP2496309B1 (fr) Préparation cosmétique contenant des cétéarylsulfosuccinates ainsi que des filtres uv liquides
DE202006011471U1 (de) Sonnenschutzmittel mit (2-Hydroxyethyl)harnstoff
DE202006011832U1 (de) Kosmetische Emulsion mit Alpha-Benzoylzimtsäurenitril
WO2014127928A1 (fr) Produit de protection solaire contenant des dialkylesters, destiné à être utilisé sur une peau humide
EP2630947B1 (fr) Préparation cosmétique imperméable et au parfum stable
DE102007024346A1 (de) Kosmetische Zubereitung mit ionischem UV-A-Filter und 2-(4&#39;-Diethylamino-2&#39;hydoxybenzoyl)-benzoesäurehexylester
DE102007024347A1 (de) Kosmetische Zubereitung mit ionischem UV-A-Filter und Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin
DE102007024348A1 (de) Kosmetische Zubereitung mit ionischem UV-A-Filter und 2,4,6-Tris-(biphenyl)-1,3,5-triazin
EP3125863A1 (fr) Procédé de protection de la peau contre le rayonnement uv

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14700610

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2014700610

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014700610

Country of ref document: EP